Impstoffwerk gets €40m injection from EIB
million to Germany's Impfstoffwerk Dessau-Tornau - a developer and
contract manufacturer of pharmaceutical and veterinary medicines -
to help it build a new research and development building and a
production facility for virus vaccines.
The loan would also part-fund the reconstruction of a filling unit, the expansion of existing cooling, storage and vaccine production facilities plus investments in equipment, according to the company, which reported annual sales of €57m in 2003.
The overall cost of these projects is estimated at €100m and will create 197 jobs in the company's eastern German region of Saxony-Anhalt, while safeguarding others at IDT, which is part of the Klocke Group.
Aside from its activities in animal vaccines, IDT is developing vaccines for use in humans and against diseases such as AIDS, malaria and smallpox. The firm's pharmaceuticals business unit carries out development and manufacturing on behalf of customers, embracing virtually all parenteral dosage forms and handling services from galenical development through to final packaging stages. It employs approximately 300 employees at present.
